KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 99 filers reported holding KURA ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,150,000 | -60.4% | 225,000 | -47.1% | 1.13% | -51.5% |
| Q3 2021 | $7,960,000 | -45.5% | 425,000 | -39.3% | 2.33% | -42.0% |
| Q2 2021 | $14,595,000 | -14.0% | 700,000 | +16.7% | 4.01% | +0.6% |
| Q1 2021 | $16,962,000 | +59.8% | 600,000 | +84.6% | 3.99% | +68.6% |
| Q4 2020 | $10,615,000 | +54.0% | 325,000 | +44.4% | 2.36% | +18.7% |
| Q3 2020 | $6,894,000 | +71.3% | 225,000 | -2.2% | 1.99% | +132.8% |
| Q3 2018 | $4,025,000 | -3.8% | 230,000 | 0.0% | 0.86% | -30.5% |
| Q2 2018 | $4,186,000 | – | 230,000 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |